Skip to menu Skip to content Skip to footer

An early phase, open label, multi-centre trial of front-line TheRapy for EBv-associated Lymphomas -- 2: TREBL-2 (Stream 6) (2022-2027)

Experts

Associate Professor Colm Keane

Principal Research Fellow
Frazer Institute
Faculty of Medicine
Colm Keane